| 000 | 01458 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515103424.0 | ||
| 264 | 0 | _c20080225 | |
| 008 | 200802s 0 0 fre d | ||
| 022 | _a0761-8425 | ||
| 024 | 7 |
_a10.1016/s0761-8425(07)74271-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLagier, J C | |
| 245 | 0 | 0 |
_a[Anti-TNF alpha therapy: a risk factor for legionella infection]. _h[electronic resource] |
| 260 |
_bRevue des maladies respiratoires _cNov 2007 |
||
| 300 |
_a1159-60 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aLegionellosis _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOpportunistic Infections _xdiagnosis |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aAndriamanantena, D | |
| 700 | 1 | _aDamiano, J | |
| 700 | 1 | _aDot, J M | |
| 700 | 1 | _aChaudier, B | |
| 700 | 1 | _aMargery, J | |
| 773 | 0 |
_tRevue des maladies respiratoires _gvol. 24 _gno. 9 _gp. 1159-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0761-8425(07)74271-7 _zAvailable from publisher's website |
| 999 |
_c17686715 _d17686715 |
||